Northern Trust Corp Tonix Pharmaceuticals Holding Corp. Transaction History

Northern Trust Corp

  • $586 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$0.46 - $1.3 $23,693 - $66,959
51,507 Added 102.24%
101,887 $60,000
Q4 2022

Feb 13, 2023
SELL
$0.29 - $0.57 $0 - $1
-3 Reduced 0.01%
50,380 $19,000
Q3 2022

Nov 14, 2022
BUY
$0.53 - $1.9 $13,566 - $48,634
25,597 Added 103.27%
50,383 $27,000
Q2 2022

Aug 12, 2022
BUY
$1.58 - $7.36 $39,161 - $182,424
24,786 New
24,786 $39,000

About Tonix Pharmaceuticals Holding Corp.

TNXP Quotes by TradingView
  • Ticker TNXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,752,700
  • Market Cap $7.81M
  • Description
  • Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candid...
More about TNXP
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email